---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-222116"
form_type: "8-K"
ticker: "WHWK"
cik: "0001422142"
company_name: "Whitehawk Therapeutics, Inc."
filed_at: "2024-09-19T23:59:59+00:00"
generated_at: "2026-05-31T03:35:22.987428+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aadi Bioscience approves retention bonuses for CEO ($390K) and CFO ($220K) through Mar 2025 or change of control

## Summary
- CEO David J. Lennon eligible for $390,000 retention bonus if employed through Mar 31, 2025 or Change of Control.
- CFO Scott Giacobello eligible for $220,000 retention bonus under same conditions.
- If terminated without cause or resign for good reason before retention date, severance payment equal to bonus (subject to release).
- Retention bonus program approved by Compensation Committee on Sept 15, 2024; letters executed Sept 18, 2024.
- No change in at-will employment status; bonus is not part of base compensation.

## SEC filing metadata
- accession: 0001193125-24-222116
- form_type: 8-K
- ticker: WHWK
- cik: 0001422142
- company_name: Whitehawk Therapeutics, Inc.
- filed_at: 2024-09-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422142/000119312524222116/0001193125-24-222116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422142/000119312524222116/d880684d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-222116
- JSON: https://secwatch.observer/filing/0001193125-24-222116.json
- Plain text: https://secwatch.observer/filing/0001193125-24-222116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.